Cargando…

The Challenge of Potential Drug–Drug Interactions Among People Living With HIV on Antiretroviral Therapy: A Cross-Sectional Study in Selected Provinces in China

OBJECTIVES: Potential drug–drug interactions (DDIs) are a significant therapeutic threat among human immunodeficiency virus (HIV)-positive individuals on antiretroviral (ARV) medications. DDIs involving ARV drugs in mainland China are unknown and insufficiently described. Herein, we investigated the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Huan, Gao, Liying, Gong, Xiaowen, Zaongo, Silvere D., Zhang, Tong, Wu, Hao, Ma, Ping, Huang, Xiaojie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266979/ https://www.ncbi.nlm.nih.gov/pubmed/32536872 http://dx.doi.org/10.3389/fphar.2020.00800

Ejemplares similares

Efficacy and Safety of Direct-Acting Antiviral Therapy in Patients With Chronic Hepatitis C Virus Infection: A Real-World Single-Center Experience in Tianjin, China
por: Xia, Huan, et al.
Publicado: (2020)

Transmitted Drug Resistance in Antiretroviral Therapy-Naive Persons With Acute/Early/Primary HIV Infection: A Systematic Review and Meta-Analysis
por: Guo, Chunxiang, et al.
Publicado: (2021)

Microbiota-Meditated Immunity Abnormalities Facilitate Hepatitis B Virus Co-Infection in People Living With HIV: A Review
por: Ouyang, Jing, et al.
Publicado: (2022)

Nanodelivery of antiretroviral drugs to nervous tissues
por: Lawal, Sodiq Kolawole, et al.
Publicado: (2022)

Delamanid Coadministered with Antiretroviral Drugs or Antituberculosis Drugs Shows No Clinically Relevant Drug-Drug Interactions in Healthy Subjects
por: Mallikaarjun, Suresh, et al.
Publicado: (2016)

Current drugs for HIV-1: from challenges to potential in HIV/AIDS
por: Peng, Yuan, et al.
Publicado: (2023)

Drug–Drug Interactions Based on Pharmacogenetic Profile between Highly Active Antiretroviral Therapy and Antiblastic Chemotherapy in Cancer Patients with HIV Infection
por: Berretta, Massimiliano, et al.
Publicado: (2016)

PSGL-1, a Strategic Biomarker for Pathological Conditions in HIV Infection: A Hypothesis Review
por: Zaongo, Silvere D., et al.
Publicado: (2023)

Drug resistance mutations among people living with HIV with treatment failure in Henan Province, China
por: Liu, Jinjin, et al.
Publicado: (2023)

HIV drug resistance in HIV positive individuals under antiretroviral treatment in Shandong Province, China
por: Lin, Bin, et al.
Publicado: (2017)

Are HIV-1-Specific Antibody Levels Potentially Useful Laboratory Markers to Estimate HIV Reservoir Size? A Review
por: Zaongo, Silvere D., et al.
Publicado: (2021)

Interactions of antiretroviral drugs with the SLC22A1 (OCT1) drug transporter
por: Moss, Darren M., et al.
Publicado: (2015)

Analysis of Clinical Drug-Drug Interaction Data To Predict Magnitudes of Uncharacterized Interactions between Antiretroviral Drugs and Comedications
por: Stader, Felix, et al.
Publicado: (2018)

Metformin may be a viable adjunctive therapeutic option to potentially enhance immune reconstitution in HIV-positive immunological non-responders
por: Zaongo, Silvere D., et al.
Publicado: (2023)

Direct-acting antiviral treatments display excellent outcomes even in older HCV-infected patients at increased risk of fibrosis
por: Xia, Huan, et al.
Publicado: (2021)

Torsade de pointes associated with long-term antiretroviral drugs in a patient with HIV: a case report
por: Mu, Xuechun, et al.
Publicado: (2023)

Barriers and Enablers for Adherence to Antiretroviral Therapy Among People Living With HIV/AIDS in the Era of COVID-19: A Qualitative Study From Pakistan
por: Ahmed, Ali, et al.
Publicado: (2022)

Prevalence, beliefs and impact of drug-drug interactions between antiretroviral therapy and illicit drugs among people living with HIV in Spain
por: Castro-Granell, Vanessa, et al.
Publicado: (2021)

Progressive Multifocal Leukoencephalopathy Diagnosed by Metagenomic Next-Generation Sequencing of Cerebrospinal Fluid in an HIV Patient
por: Xia, Huan, et al.
Publicado: (2019)

Evaluation of Oral Antiretroviral Drugs in Mice With Metabolic and Neurologic Complications
por: Tsai, Fuu-Jen, et al.
Publicado: (2018)

Single-Cell Sequencing Facilitates Elucidation of HIV Immunopathogenesis: A Review of Current Literature
por: Zaongo, Silvere D., et al.
Publicado: (2022)

Anxiety, Loneliness, Drug Craving, and Depression Among Substance Abusers in Sichuan Province, China
por: Chen, Xin, et al.
Publicado: (2021)

The impact of key monitoring policy on the usage of policy-related drugs in Hubei Province, China
por: Wen, Xiaotong, et al.
Publicado: (2023)

Evolution of Drug Interactions With Antiretroviral Medication in People With HIV
por: El Moussaoui, Majdouline, et al.
Publicado: (2020)

P-Selectin Glycoprotein Ligand 1: A Potential HIV-1 Therapeutic Target
por: Zaongo, Silvere D., et al.
Publicado: (2021)

Problem-Based Learning Could Tackle the Issue of Insufficient Education and Adherence in People Living With HIV/AIDS
por: Zhang, Yang, et al.
Publicado: (2019)

Prevalence of Drug–Drug Interactions with Hormonal Contraceptives and Antiretrovirals in Women Living with HIV
por: McLaughlin, Milena M, et al.
Publicado: (2017)

The diverse roles of miRNAs in HIV pathogenesis: Current understanding and future perspectives
por: Rashid, Farooq, et al.
Publicado: (2023)

Editorial: Evidence for Assessing Drug Safety and Drug Use in Older People
por: Lopes, Luciane Cruz, et al.
Publicado: (2022)

The Impact of Contemporary Antiretroviral Drugs on Atherosclerosis and Its Complications in People Living With HIV: A Systematic Review
por: Vemulapalli, Abhijith C, et al.
Publicado: (2023)

Time to First Line Antiretroviral Therapy Adverse Drug Reaction and its Predictors Among Adult HIV/AIDS Patients on Treatment in Eastern Ethiopia
por: Weldesenbet, Adisu Birhanu, et al.
Publicado: (2022)

Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development
por: Biber, Knut, et al.
Publicado: (2019)

Prescribing issues in older adults living with HIV: thinking beyond drug–drug interactions with antiretroviral drugs
por: Livio, Françoise, et al.
Publicado: (2019)

Antiretroviral drugs efavirenz, dolutegravir and bictegravir dysregulate blood-brain barrier integrity and function
por: Huang, Chang, et al.
Publicado: (2023)

Prevalence and management of drug–drug interactions with antiretroviral treatment in 2069 people living with HIV in rural Tanzania: a prospective cohort study
por: Schlaeppi, C, et al.
Publicado: (2019)

Three-Drug Regimens Containing Integrase Inhibitor Show Good Efficacy and Safety in Treatment-Naive Patients With HIV-1: A Bayesian Analysis
por: Zhang, Ke, et al.
Publicado: (2021)

Genetic Diversity and Characteristics of Drug Resistance Among Treatment-Naive People Living with HIV in Xi’an, China
por: Xia, Huan, et al.
Publicado: (2023)

Potential risk of drug–drug interactions with hormonal contraceptives and antiretrovirals: prevalence in women living with HIV
por: Murray, Milena M, et al.
Publicado: (2020)

HIV Viral Suppression among People Living with HIV on Antiretroviral Therapy in Haut-Katanga and Kinshasa Provinces of Democratic Republic of Congo
por: Shah, Gulzar H., et al.
Publicado: (2021)

Safety and Pharmacokinetic Profiles of Long-Acting Injectable Antiretroviral Drugs for HIV-1 Pre-Exposure Prophylaxis: A Systematic Review and Meta-analysis of Randomized Trials
por: Lazarus, Gilbert, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oebf1u2rhli68rb26a6ea23n0d